Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When the SWI/SNF complex remodels...the cell cycle.

C Muchardt1, M Yaniv

  • 1Unité des Virus Oncogènes, URA1644 du CNRS, Département des Biotechnologies, Institut Pasteur, Paris, France.

Oncogene
|June 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

V osteotomy and Ilizarov technique for residual idiopathic or neurogenic clubfeet.

Journal of orthopaedic surgery (Hong Kong)·2008
Same author

Characterization of mammary tumors from Brg1 heterozygous mice.

Oncogene·2007
Same author

The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.

Oncogene·2007
Same author

Congenital absence (ankylosis) of the knee.

The Journal of bone and joint surgery. British volume·2004
Same author

Hepatocyte nuclear factor 1alpha controls the expression of terminal complement genes.

The Journal of experimental medicine·2001
Same author

A yeast homolog of chromatin assembly factor 1 is involved in early ribosome assembly.

Current biology : CB·2001
Same journal

SRD5A3-mediated aberrant N-glycosylation of SCARA5 promotes ferroptosis in lung adenocarcinoma.

Oncogene·2026
Same journal

Aberrant splicing in human cancer shows possible functional impact on transcription factors.

Oncogene·2026
Same journal

The crosstalk between RNA m6A modification and protein lactylation: emerging insights into tumor progression.

Oncogene·2026
Same journal

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Oncogene·2026
Same journal

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

Oncogene·2026
Same journal

Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.

Oncogene·2026
See all related articles

Mammalian chromatin remodelers, Brm and Brg1, are crucial for gene regulation and cell growth. Their inactivation is linked to cancer, highlighting their role in tumor suppression and cell cycle control.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Mammalian cells utilize Brm and Brg1 helicase-like proteins in chromatin-remodeling complexes, analogous to yeast SWI/SNF and RSC.
  • These complexes regulate gene activation/repression and are implicated in cell growth control.

Purpose of the Study:

  • To review the functional consequences of Brm, Brg1, and SNF5/Ini1 inactivation in mice.
  • To explore the role of these factors in Retinoblastoma (pRb)-mediated repression of the E2F transcription factor.

Main Methods:

  • Homologous recombination in mice to inactivate Brm, Brg1, and SNF5/Ini1 genes.
  • Review of existing literature on chromatin remodeling, gene regulation, and cancer.

Main Results:

Related Experiment Videos

  • Brm downregulation by ras signaling suppresses oncogenic transformation.
  • Brg1 mutations/silencing occur in tumor cell lines; Brg1 complexes associate with BRCA1.
  • SNF5/Ini1 inactivation is observed in aggressive pediatric rhabdoid sarcomas.

Conclusions:

  • Brm, Brg1, and SNF5/Ini1 are critical regulators of cell growth and tumor suppression.
  • These chromatin remodelers likely play a significant role in pRb-E2F pathway regulation.